AU2001284113A1 - Novel diamines having a casr modulating activity - Google Patents
Novel diamines having a casr modulating activityInfo
- Publication number
- AU2001284113A1 AU2001284113A1 AU2001284113A AU8411301A AU2001284113A1 AU 2001284113 A1 AU2001284113 A1 AU 2001284113A1 AU 2001284113 A AU2001284113 A AU 2001284113A AU 8411301 A AU8411301 A AU 8411301A AU 2001284113 A1 AU2001284113 A1 AU 2001284113A1
- Authority
- AU
- Australia
- Prior art keywords
- casr
- modulating activity
- novel diamines
- diamines
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101150027751 Casr gene Proteins 0.000 title 1
- 150000004985 diamines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/26—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0010427A FR2812875B1 (en) | 2000-08-08 | 2000-08-08 | NOVEL DIAMINES HAVING CASR MODULATING ACTIVITY AND THEIR METHOD OF PREPARATION |
| FR0010427 | 2000-08-08 | ||
| PCT/FR2001/002562 WO2002012181A1 (en) | 2000-08-08 | 2001-08-07 | Novel diamines having a casr modulating activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001284113A1 true AU2001284113A1 (en) | 2002-02-18 |
Family
ID=8853394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001284113A Abandoned AU2001284113A1 (en) | 2000-08-08 | 2001-08-07 | Novel diamines having a casr modulating activity |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7157498B2 (en) |
| EP (1) | EP1409453A1 (en) |
| JP (1) | JP4896350B2 (en) |
| AU (1) | AU2001284113A1 (en) |
| FR (1) | FR2812875B1 (en) |
| WO (1) | WO2002012181A1 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8362274B2 (en) | 2004-05-28 | 2013-01-29 | Mitsubishi Tanabe Pharma Corporation | Arylalkylamine compound and process for preparing the same |
| US7361789B1 (en) | 2004-07-28 | 2008-04-22 | Amgen Inc. | Dihydronaphthalene compounds, compositions, uses thereof, and methods for synthesis |
| FR2885129B1 (en) * | 2005-04-29 | 2007-06-15 | Proskelia Sas | NOVEL DERIVATIVES OF UREEE SUBSTITUTED WITH THIAZOLE OR BENZOTHIAZOLE, PROCESS FOR THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THE USE THEREOF |
| EP1965805B1 (en) * | 2005-11-25 | 2009-12-02 | Galapagos SAS | Urea derivatives useful as calcium receptor modulators |
| WO2007124465A2 (en) * | 2006-04-20 | 2007-11-01 | Amgen Inc. | Stable emulsion formulations |
| WO2008057282A1 (en) * | 2006-10-26 | 2008-05-15 | Amgen Inc. | Calcium receptor modulating agents |
| CA2681582C (en) | 2007-03-30 | 2015-07-14 | Amgen Inc. | Methods of treating bowel disorders |
| CA2701792A1 (en) * | 2007-10-15 | 2009-04-23 | Amgen Inc. | Calcium receptor modulating agents |
| WO2010042642A1 (en) * | 2008-10-08 | 2010-04-15 | Amgen Inc. | Calcium receptor modulating agents |
| WO2010104882A1 (en) | 2009-03-10 | 2010-09-16 | Amgen Inc. | Methods of modulating sperm motility |
| WO2010136035A2 (en) | 2009-05-27 | 2010-12-02 | Leo Pharma A/S | Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| EP2435404A1 (en) | 2009-05-27 | 2012-04-04 | Leo Pharma A/S | Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| US8946474B2 (en) | 2010-06-30 | 2015-02-03 | Leo Pharma A/S | Polymorphic form of a calcimimetic compound |
| WO2012000498A1 (en) | 2010-06-30 | 2012-01-05 | Leo Pharma A/S | New polymorphic form of a calcimimetic compound |
| WO2012069420A2 (en) | 2010-11-26 | 2012-05-31 | Leo Pharma A/S | Calcium-sensing receptor-active compounds |
| RU2013128973A (en) | 2010-11-26 | 2015-01-10 | Лео Фарма А/С | COMPOUNDS ACTIVE AGAINST CALCIUM-SENSITIVE RECEPTORS |
| CN103228629A (en) | 2010-11-26 | 2013-07-31 | 利奥制药有限公司 | Substituted cyclopentyl -azines as CaSR- active compounds |
| WO2012069419A1 (en) | 2010-11-26 | 2012-05-31 | Leo Pharma A/S | Calcium-sensing receptor-active compounds |
| WO2012120476A1 (en) | 2011-03-10 | 2012-09-13 | Lupin Limited | Substituted morpholines as modulators for the calcium sensing receptor |
| WO2012127388A1 (en) | 2011-03-18 | 2012-09-27 | Lupin Limited | Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators |
| CU24325B1 (en) | 2012-02-24 | 2018-03-13 | Lupin Atlantis Holdings Sa | CHROME COMPOUNDS REPLACED AS CALCIUM SENSITIVE RECEIVER MODULAR TO TREAT DISEASES OR DISORDERS ASSOCIATED WITH THESE MODULATORS |
| WO2013136288A1 (en) | 2012-03-16 | 2013-09-19 | Lupin Limited | Substituted 3,4-dihydro-2h-benzo[b] [1,4]oxazine compounds as calcium sensing receptor modulators |
| WO2014033604A1 (en) | 2012-08-27 | 2014-03-06 | Lupin Limited | Arylalkylamine compounds as calcium sensing receptor modulators |
| GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
| TW201602062A (en) | 2013-08-12 | 2016-01-16 | 魯賓有限公司 | Substituted biphenyl compounds as calcium sensing receptor modulators |
| CA2920818A1 (en) | 2013-08-28 | 2015-03-05 | Lupin Limited | Substituted naphthalene compounds as calcium sensing receptor modulators |
| WO2015162538A1 (en) | 2014-04-21 | 2015-10-29 | Lupin Limited | Heterocyclic compounds as calcium sensing receptor modulators for the treatment of hyperparathyroidism, chronic renal failure and chronic kidney disease |
| WO2017037616A1 (en) | 2015-08-31 | 2017-03-09 | Lupin Limited | Arylalkylamine compounds as calcium sensing receptor modulators |
| BR112022012663A2 (en) | 2019-12-27 | 2022-09-06 | Lupin Ltd | PHARMACEUTICAL COMPOSITION OF CASR MODULATORS AND METHODS AND USES THEREOF |
| FI4090654T3 (en) | 2020-01-17 | 2025-09-30 | Lupin Ltd | Methods, processes and intermediates for preparing chroman compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3262977A (en) * | 1962-03-10 | 1966-07-26 | Chinoin Gyogyszer Es Vegyeszet | N-aralkyl-1, 1-diphenyl-propylamine derivatives |
| ATE312347T1 (en) * | 1991-08-23 | 2005-12-15 | Nps Pharma Inc | SCREENING METHOD FOR CALCIUM RECEPTOR ACTIVE COMPOUNDS |
| WO1995011221A1 (en) * | 1991-08-23 | 1995-04-27 | Nps Pharmaceuticals, Inc. | Calcium receptor-active arylalkyl amines |
| WO1997037967A1 (en) | 1996-04-09 | 1997-10-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
| EP0907631B1 (en) * | 1996-05-01 | 2003-06-18 | Nps Pharmaceuticals, Inc. | Inorganic ion receptor-active compounds |
| JP2001519813A (en) | 1997-04-04 | 2001-10-23 | スミスクライン・ビーチャム・コーポレイション | Calcium soluble compounds |
| UY24949A1 (en) | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | CALCILITE COMPOUNDS |
| AR018177A1 (en) | 1998-04-08 | 2001-10-31 | Smithkline Beecham Corp | CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. |
| AR014975A1 (en) | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
-
2000
- 2000-08-08 FR FR0010427A patent/FR2812875B1/en not_active Expired - Fee Related
-
2001
- 2001-08-07 EP EP20010963065 patent/EP1409453A1/en not_active Withdrawn
- 2001-08-07 JP JP2002518159A patent/JP4896350B2/en not_active Expired - Fee Related
- 2001-08-07 AU AU2001284113A patent/AU2001284113A1/en not_active Abandoned
- 2001-08-07 US US10/344,146 patent/US7157498B2/en not_active Expired - Fee Related
- 2001-08-07 WO PCT/FR2001/002562 patent/WO2002012181A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2812875B1 (en) | 2003-12-12 |
| EP1409453A1 (en) | 2004-04-21 |
| JP2004505949A (en) | 2004-02-26 |
| JP4896350B2 (en) | 2012-03-14 |
| US20050192317A1 (en) | 2005-09-01 |
| FR2812875A1 (en) | 2002-02-15 |
| WO2002012181A1 (en) | 2002-02-14 |
| US7157498B2 (en) | 2007-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001284113A1 (en) | Novel diamines having a casr modulating activity | |
| AUPQ855800A0 (en) | Dispenser head | |
| AU2002318018A1 (en) | A tampon | |
| AU2002244901A1 (en) | A baler | |
| AU4163000A (en) | A spreader | |
| AUPQ643100A0 (en) | A toothbrush | |
| AU2542301A (en) | A planar transformer | |
| AU5648701A (en) | A printer | |
| AU2001274894A1 (en) | Novel matrix metalloproteinases | |
| AU2002334372A1 (en) | A rounded rectangular gemstone | |
| AU4162900A (en) | A spreader | |
| AU2002243528A1 (en) | A straw | |
| AUPQ567900A0 (en) | A wok | |
| AU1782201A (en) | 2786, a novel human aminopeptidase | |
| AU2001291761A1 (en) | Microcapsules | |
| AU2002220530A1 (en) | A lure | |
| AU2002366300A1 (en) | A phantom | |
| AU2001289902A1 (en) | Novel herbicides | |
| AU2002216484A1 (en) | A brush | |
| AU2002300428A1 (en) | A Distributor Plate | |
| AU2001294455A1 (en) | A link-twisting arrangement | |
| AU2001283380A1 (en) | 17903, a human aminopeptidase and uses therefor | |
| AU2002221613A1 (en) | Novel herbicides | |
| AUPR204900A0 (en) | A novel gene | |
| AU2001289663A1 (en) | Asymmetric dihydrotriazines as pesticides |